Internal Data Analytics as a Foundation of a Strategic Plan

Eye Practice Strategic Performance Points of Analysis:
  1. Patient experience; including factors that affect strategic performance of the the practice such as new patient access, return appointment access, urgent care availability and organized programming focused on chronic conditions.
  2. Referral source management; growth and development of the referral base; type of patients referred by external providers (by specialty, presenting problem, geography, etc.)
  3. Patient self-referral; presenting reason by demographic cohort and geographic market.
  4. Creation of demand for clinical services by service/ program, from aninstalled patient base; how the installed base responds to the availability of services and programs promoted.
  5. Payer mix state and trajectory; for new and existing patients with analysis of reimbursement rates per services provided and out-of-pocket expenses required from patients per payer plan.
  6. Provider productivity, by WRVU, arranged by major type of clinical service and providers (new and established patients.)
  7. Patient diagnosis and complexity analysis across the practice; a profile of the patients by clinical type and provider type (e.g., ophthalmologists and optometrists.)
  8. Revenues by major clinical service and patient diagnostic category and WRVU's generated per payer class.
  9. Out-of-practice patient referrals by provider, including reason and referral source.
  10. Net revenue productivity per non-provider full-time equivalent (FTE.) This is a measure of non-provider staff productivity and trends.
  11. Net revenue productivity trajectory per WRVU produced; the net revenue earned per average provider WRVU produced.
  12. Owner (or provider) compensation trajectory per WRVU produced.
  13. Relationship of non-surgical WRVU's produced to surgical (and other complex units of service.)
  14. Net revenue allocations for major enterprise services/ products sold; clinic, surgical, optical, ATL's, etc. per average WRVU produced.)
  15. Ratio of non-surgical WRVU's to surgical.
  16. Allocation of new patients by provider, including presenting problem.

About Daniel K. Zismer, Ph. D.

Daniel K. Zismer, Ph. D.

Daniel K. Zismer, Ph.D. Is the Co-Chair, Co-Founder and CEO of Associated Eye Care Partners. He is also Endowed Scholar, Professor Emeritus and Chair, Department of Healthcare Administration, School of Public Health, University of Minnesota.

Read more →

Subscribe for news and updates.

Thank you for subscribing!
Check your inbox shortly for a confirmation email.
Oops! Something went wrong. Please try again or contact be added manually.